McKESSON CORPORATION (MCK) FY2027 Q1 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
McKESSON CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Proceeds from issuances of long-term debt → financing reconciliation: $3,215,000,000.00Sale of noncontrolling interest in Medical-Surgical Solutions, net → financing reconciliation: $1,238,000,000.00Issuances → financing reconciliation: $23,000,000.00financing reconciliation → Net cash from financing activities: $1,632,000,000.00financing reconciliation → Share repurchases: $2,530,000,000.00financing reconciliation → Other: $211,000,000.00financing reconciliation → Dividends paid: $102,000,000.00financing reconciliation → Repayments of long-term debt: $1,000,000.00Proceeds from sales of businesses and investments, net → investing reconciliation: $9,000,000.00investing reconciliation → Payments for property, plant, and equipment: $112,000,000.00investing reconciliation → Other: $48,000,000.00investing reconciliation → Capitalized software expenditures: $40,000,000.00investing reconciliation → Acquisitions, net of cash, cash equivalents, and restricted cash acquired: $23,000,000.00Net cash used in operating activities → operating reconciliation: $220,000,000.00Net income → operating reconciliation: $1,032,000,000.00Drafts and accounts payable → operating reconciliation: $3,773,000,000.00Amortization → operating reconciliation: $126,000,000.00Other non-cash items → operating reconciliation: $76,000,000.00Depreciation → operating reconciliation: $69,000,000.00Non-cash operating lease expense → operating reconciliation: $66,000,000.00Asset impairment charges → operating reconciliation: $47,000,000.00Provision for bad debts → operating reconciliation: $45,000,000.00Deferred taxes → operating reconciliation: $19,000,000.00operating reconciliation → Receivables: $2,374,000,000.00operating reconciliation → Inventories: $2,074,000,000.00operating reconciliation → Taxes: $538,000,000.00operating reconciliation → Other: $380,000,000.00operating reconciliation → Operating lease liabilities: $65,000,000.00operating reconciliation → Litigation liabilities: $34,000,000.00operating reconciliation → Loss (gain) from sales of businesses and investments: $6,000,000.00operating reconciliation → Credits associated with last-in, first-out inventory method: $2,000,000.00Net cash used in investing activities → investing reconciliation: $214,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $4,068,000,000.00Net cash from financing activities → Cash sources and uses: $1,632,000,000.00Cash sources and uses → Exchange-rate effect: $10,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $5,256,000,000.00Cash sources and uses → Net cash used in investing activities: $214,000,000.00Cash sources and uses → Net cash used in operating activities: $220,000,000.00Net income: $1,032,000,000.00Net income+$1.03 BDepreciation: $69,000,000.00Depreciation expense+$69.00 MAmortization: $126,000,000.00Amortization expense+$126.00 MAsset impairment charges: $47,000,000.00Other asset impairments+$47.00 MDeferred taxes: $19,000,000.00Deferred tax balances+$19.00 MCredits associated with last-in, first-out inventory method: -$2,000,000.00Inventory reserve provision−$2.00 MNon-cash operating lease expense: $66,000,000.00Non-cash lease expense+$66.00 MLoss (gain) from sales of businesses and investments: -$6,000,000.00Other asset gain & loss−$6.00 MProvision for bad debts: $45,000,000.00Credit loss provision+$45.00 MOther non-cash items: $76,000,000.00Other non-cash items+$76.00 MReceivables: -$2,374,000,000.00Receivables, net−$2.37 BInventories: -$2,074,000,000.00Inventories−$2.07 BDrafts and accounts payable: $3,773,000,000.00Accounts payable+$3.77 BOperating lease liabilities: -$65,000,000.00Operating lease liabilities−$65.00 MTaxes: -$538,000,000.00Accrued taxes−$538.00 MLitigation liabilities: -$34,000,000.00Litigation liabilities−$34.00 MOther: -$380,000,000.00Other working capital, net−$380.00 MNet cash used in operating activities: -$220,000,000.00. Cash required to fund net payments.Operating cash−$220.00 Moperating reconciliation: $5,473,000,000.00Proceeds from issuances of long-term debt: $3,215,000,000.00Long-term debt issued+$3.22 BRepayments of long-term debt: -$1,000,000.00Long-term debt repaid−$1.00 MIssuances: $23,000,000.00Employee stock plans & options+$23.00 MShare repurchases: -$2,530,000,000.00Common stock repurchases−$2.53 BDividends paid: -$102,000,000.00Common dividends paid−$102.00 MOther: -$211,000,000.00Other financing, net−$211.00 MSale of noncontrolling interest in Medical-Surgical Solutions, net: $1,238,000,000.00Medical-Surgical NCI sale, net+$1.24 BNet cash from financing activities: $1,632,000,000.00Financing cash+$1.63 Bfinancing reconciliation: $4,476,000,000.00Payments for property, plant, and equipment: -$112,000,000.00PP&E purchases−$112.00 MCapitalized software expenditures: -$40,000,000.00Software purchases−$40.00 MProceeds from sales of businesses and investments, net: $9,000,000.00Business & affiliate sales+$9.00 MOther: -$48,000,000.00Other investing, net−$48.00 MAcquisitions, net of cash, cash equivalents, and restricted cash acquired: -$23,000,000.00Acquisitions, net of cash−$23.00 MNet cash used in investing activities: -$214,000,000.00. Cash required to fund net payments.Investing cash−$214.00 Minvesting reconciliation: $223,000,000.00Cash sources and uses: $5,700,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $4,068,000,000.00Beginning cash$4.07 BEnding cash: Cash, cash equivalents, and restricted cash: $5,256,000,000.00Ending cash$5.26 BExchange-rate effect: -$10,000,000.00FX effect−$10.00 MCASH RECONCILIATIONFinancingflowsInvestingflowsOperatingflowsFree cash flow−$332.00 MOperating cash − cash spent on PP&ECash flow / Net income−0.21×Operating cash flow ÷ net incomeNet cash change+$1.19 BEnding cash − beginning cash
Chart details

McKESSON CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
4,068,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
negative 220,000,000 US dollars. Net cash used.
Net income
1,032,000,000 US dollars
Depreciation
69,000,000 US dollars
Amortization
126,000,000 US dollars
Asset impairment charges
47,000,000 US dollars
Deferred taxes
19,000,000 US dollars
Credits associated with last-in, first-out inventory method
negative 2,000,000 US dollars
Non-cash operating lease expense
66,000,000 US dollars
Loss (gain) from sales of businesses and investments
negative 6,000,000 US dollars
Provision for bad debts
45,000,000 US dollars
Other non-cash items
76,000,000 US dollars
Receivables
negative 2,374,000,000 US dollars
Inventories
negative 2,074,000,000 US dollars
Drafts and accounts payable
3,773,000,000 US dollars
Operating lease liabilities
negative 65,000,000 US dollars
Taxes
negative 538,000,000 US dollars
Litigation liabilities
negative 34,000,000 US dollars
Other
negative 380,000,000 US dollars
Investing activities
negative 214,000,000 US dollars. Net cash used.
Payments for property, plant, and equipment
negative 112,000,000 US dollars
Capitalized software expenditures
negative 40,000,000 US dollars
Proceeds from sales of businesses and investments, net
9,000,000 US dollars
Other
negative 48,000,000 US dollars
Acquisitions, net of cash, cash equivalents, and restricted cash acquired
negative 23,000,000 US dollars
Financing activities
1,632,000,000 US dollars. Net cash provided.
Proceeds from issuances of long-term debt
3,215,000,000 US dollars
Repayments of long-term debt
negative 1,000,000 US dollars
Issuances
23,000,000 US dollars
Share repurchases
negative 2,530,000,000 US dollars
Dividends paid
negative 102,000,000 US dollars
Other
negative 211,000,000 US dollars
Sale of noncontrolling interest in Medical-Surgical Solutions, net
1,238,000,000 US dollars
Operating adjustment reconciliation
5,473,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
4,476,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
223,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 10,000,000 US dollars
Ending cash on Jun 30, 2026
5,256,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
5,700,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
1,188,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
−0.21×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
negative 220,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
112,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
negative 332,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income or operating cash is negative. The full signed reconciliation is retained: losses remain deductions, and any negative operating-cash total enters the junction from the cash pool. No positive direct-income connection is implied.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 220,000,000 US dollars minus 112,000,000 US dollars equals negative 332,000,000 US dollars.
McKESSON CORPORATION (MCK) FY2027 Q1 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!